Johnson & Johnson
Filipe Schmidt is an accomplished Technology Director and Digital Transformation Leader at Johnson & Johnson, with over a decade of experience driving significant IT initiatives, particularly in the Supply Chain ERP Products sector. Under Filipe's leadership, a global Digital Transformation program has been advanced to optimize MedTech Supply Chain operations through innovative technologies, aligning standardization and enhancing digital capacities. Notably, Filipe oversees the Global Ethicon Transformation project, focusing on the integration of SAP S/4HANA to establish a new digital core for the enterprise. With a robust background in ERP implementation and site leadership across multiple manufacturing locations, Filipe has successfully spearheaded numerous strategic initiatives, demonstrating expertise in project management, business process improvement, and technology integration. Educational credentials include an Executive MBA from MIT Sloan School of Management and a specialization in Big Data from UC San Diego.
This person is not in any offices
Johnson & Johnson
541 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.